Emerging Market Companies and Investor Updates Provided by BrokerBank Securities, Inc.

NEW YORK, June 26, 2014 /PRNewswire/ -- NYBD Holding, Inc. (OTCBB: NYBD) has filed for a name change and it has been accepted. The company will now be trading under (AQUA), will be named Pleasant Kids, Inc. and  the company is expecting the name and symbol change to take affect within the next few business days.

The company is launching a national marketing campaign called "WHERE HEALTHY BEGINS." Get all the details in the report that follows: http://bit.ly/-NYBD-InvestorUpdate

Ekso Bionics Holdings, Inc. (OTCQB: EKSO) Ekso Bionics is pioneering the field of robotic exoskeletons, or wearable robots, to augment human strength, endurance and mobility. The company's first commercially available product called Ekso has helped thousands of people living with paralysis take millions of steps not otherwise possible. By designing and creating some of the most forward-thinking and innovative solutions for people looking to augment human capabilities.

Get the details of this exciting new technology by reading the report at the following link: http://bit.ly/-EKSO-InvestorUpdate

Rainbow International Corp. (OTCQB: RNBI) The company's purpose is to capitalize on the re-emergence of the commercial production of hemp, by growing hemp in greenhouses and on acreage, then formulate, package and distribute its own unique line of hemp-based products.

Rainbow International Corp. has recently undergone a management change and a new division to manufacture and distribute a premier product line under the name of CBD Group, a series of topical pain remedies using homeopathic ingredients is developed from industrial cannabidiol (CBD).

RNBI is impacted by Colorado rules regarding hemp production. Read about how the company is impacted by reading the report at this link: http://bit.ly/-RNBI-InvestorUpdate

Legends Business Group, Inc. (OTCBB: LGBS) focuses on the development and marketing of alternative and exotic energy products and technology. The company is developing self-sustaining energy sources, alternative energy power magnifiers, power boosters, and power storage regenerators. It also sells solar, wind, and electric charging products.

The company has announced a new business direction into the cannabis market. Get the information about the progress toward this goal at the link: http://bit.ly/-LGBS-InvestorUpdate

Nutra Pharma Corp. (OTCBB: NPHC) operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases, including Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain. Additionally, the Company markets several drug products for sale for the treatment of pain under the brands Cobroxin® and Nyloxin®.

The company is going to advertise its pain reliever Nyloxin on television. Read about the company marketing plan at the following link: http://bit.ly/-NPHC-InvestorUpdate

FORWARD-LOOKING DISCLAIMER 

This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward- looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein. 

COMPLIANCE PROCEDURE 

Content is researched, written and reviewed on a best-effort basis. This document, article or report is written and authored by Mark Bonacci. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. We do not engage in high frequency trading.

A full disclaimer can be found by viewing the full analyst report.

If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected]. For any urgent concerns or inquiries please contact us at [email protected]. 

BrokerBank Securities, Inc. is a member of the Financial Industry Regulatory Authority, CRD number #130116.

SOURCE BrokerBank Securities, Inc.